2023
Risk Factors Related to Transient Diabetes Insipidus Development Following Transsphenoidal Pituitary Adenoma Resection: A Multicentric Study
Yasuda M, Renedo D, Sosa S, Danilowicz K, Recalde R, Zaninovich R, Abbati S, Cervio A, Giovannini S, Villalonga J, Ulloque-Caamaño L, Reddy K, Socolovsky M, Campero A. Risk Factors Related to Transient Diabetes Insipidus Development Following Transsphenoidal Pituitary Adenoma Resection: A Multicentric Study. World Neurosurgery 2023, 175: e636-e643. PMID: 37030477, DOI: 10.1016/j.wneu.2023.03.150.Peer-Reviewed Original ResearchConceptsGross total resectionTrans-sphenoidal surgeryPituitary adenoma resectionRisk factorsPostoperative DITotal resectionAdenoma resectionMultivariable modelFemale genderTranssphenoidal pituitary adenoma resectionMultivariate logistic regression modelDifferent neurosurgical centersMulticenter case seriesIndependent risk factorMean tumor sizeSignificant predictorsLogistic regression analysisLogistic regression modelsTransient DITransient diabetesYounger patientsCase seriesMean ageTumor sizeMulticentric study
2022
Higher Hospital Frailty Risk Score is associated with increased complications and healthcare resource utilization after endovascular treatment of ruptured intracranial aneurysms
Koo AB, Elsamadicy AA, Renedo D, Sarkozy M, Sherman J, Reeves BC, Havlik J, Antonios J, Sujijantarat N, Hebert R, Malhotra A, Matouk C. Higher Hospital Frailty Risk Score is associated with increased complications and healthcare resource utilization after endovascular treatment of ruptured intracranial aneurysms. Journal Of NeuroInterventional Surgery 2022, 15: 255-261. PMID: 35292571, PMCID: PMC8931798, DOI: 10.1136/neurintsurg-2021-018484.Peer-Reviewed Original ResearchConceptsHospital Frailty Risk ScoreNon-routine dischargeLength of stayFrailty Risk ScoreHealthcare resource utilizationTotal hospital costsEndovascular treatmentIntracranial aneurysmsAdverse eventsHospital costsRisk scoreHighest Hospital Frailty Risk ScoresMean LOSNational Inpatient Sample databaseMean total hospital costMultivariate logistic regression analysisImpact of frailtyRetrospective cohort studyICD-10-CM codesLogistic regression analysisRegression analysisMultivariate regression analysisCohort studyDischarge dispositionPatient demographics
2021
Approach to the Superior Ophthalmic Vein for Endovascular Treatment of Cavernous Dural Fistula
Iglesias B, Yasuda M, Renedo D, Weil D, Racana I, Goland J, Garbugino S. Approach to the Superior Ophthalmic Vein for Endovascular Treatment of Cavernous Dural Fistula. World Neurosurgery 2021, 151: 1. PMID: 33862293, DOI: 10.1016/j.wneu.2021.04.008.Peer-Reviewed Original ResearchConceptsSuperior ophthalmic veinInferior petrosal sinusOphthalmic veinDural cavernous fistulasDural fistulasCavernous fistulaPetrosal sinusOpen approachBarrow Type DIntracranial dural fistulasRed right eyeProgressive vision lossType 2 diabetesCavernous sinus areaCavernous dural fistulasIntractable glaucomaProgressive exophthalmosEndovascular treatmentVisual acuityRight eyeInterventional therapyCavernous sinusVision lossSurgery teamTransvenous approach
2020
Thalamic tumors in children: case series from our institution and literature review
Renedo D, Ferraro F, Johnson A, Argañaraz R, Giovannini S, Zabala J, Zemma E, Mantese B. Thalamic tumors in children: case series from our institution and literature review. Child's Nervous System 2020, 37: 457-463. PMID: 32712861, DOI: 10.1007/s00381-020-04830-0.Peer-Reviewed Original ResearchConceptsThalamic tumorsCase seriesSurgical approachStereotactic-guided biopsyGross total resectionEndoscopic third ventriculostomyGrade IV tumorsHigh-grade tumorsInvasive surgical proceduresTime of treatmentSubtotal resectionMedian ageVentriculoperitoneal shuntMotor deficitsGrade IIIThird ventriculostomyGrade IGrade IIObservational studySurgical proceduresPatientsResultsFrom 2013TumorsCommon formResection